Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency drugs in development, 2024

GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency by six companies/universities/institutes. The top development phase for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency is phase ii, with three drugs in that stage.

Avrobio makes way for GPCR biotech Tectonic Therapeutic in reverse merger

The path to an IPO looks a little greener in biotech these days, but private startups are still eyeing reverse mergers to land their Nasdaq

January 31, 2024

Adjustment of the forecast for revenue and EBITDA for FY 2023; implementation of a personnel measure to achieve positive EBITDA and balanced cash flow in the operating trauma business – Biotech Investments

aap Implantate AG / Key word(s): Change in Forecast/Restructure of Company Adjustment of the forecast for revenue and EBITDA for FY 2023; implementation of a

December 22, 2023

B-Cell Stimulating Factors Tied to Lymphoma in Sjogren’s

Genetic blood tests indicated that Bruton’s tyrosine kinase (BTK) and a cytokine called APRIL were overexpressed in patients with primary Sjögren’s syndrome who subsequently developed

May 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.